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Cognitive behavioural therapy (CBT) and applied relaxation are the recommended 
talking treatments for generalised anxiety disorder (GAD) in adults. No specific 
recommendations are currently available for older adults with GAD due to paucity of 
evidence. In order to contribute to the GAD older adult evidence base (1) a meta-
analysis of clinical trials has been performed and (2) a case series of providing group 
CBT has been conducted.  
The first part of the thesis reports a meta-analytic review of 14 randomized 
controlled trials of CBT for GAD in older adults. Results showed CBT to be an 
effective treatment, but did not provide conclusive evidence of superiority of CBT 
against other evidenced-based psychotherapies. Avenues for the continued 
methodological development of field are discussed.   
The second part of the thesis presents a case series study evaluating group 
delivery of an existing GAD treatment protocol with older adults. The focus of the 
study was on feasibility, acceptability and effectiveness. Mixed methods were used 
across the three main study phases (baseline, intervention and follow-up) with N=23 
eligible participants. Participant dropout was low, homework compliance high, and 
large treatment effects on the primary outcome measure of worry were found. Merged 
findings suggested the group intervention was an acceptable, feasible, effective, and 
durable treatment option. The potential of group interventions for late life GAD are 
discussed. Taken together, the two studies suggest that group format does not reduce 
the acceptability and effectiveness of treatment, and provide an opportunity for delivery 
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                                                 Abstract 
 
Objective: To review the gold standard evidence for cognitive behavioural therapy 
(CBT) for generalised anxiety disorder (GAD) in older adults, for the hallmark 
symptom of GAD, uncontrolled and excessive worry. 
 
Method: Systematic searches of relevant databases (PsychInfo, Web of Science, and 
ProQuest Dissertation and Theses) and iterative searches of references from retrieved 
articles. Studies were required to be a randomised control trial (RCT), to have used the 
Penn State Worry Questionnaire (PPSWQ/PSWQ-A) as the primary outcome measure, 
and to have conducted CBT with outpatient older adults. Random-effects meta-analyses 
and moderator analyses were conducted. 
 
Results: Fourteen RCTs met inclusion criteria (N = 985). At the end of treatment, and 
6-month follow-up, significant treatment effects favouring CBT were found when CBT 
was compared with waitlist or treatment-as-usual (TAU). One in every three older adult 
patients would be expected to find additional benefit from CBT for their GAD 
compared to TAU. When CBT was compared with active controls, however, a small 
overall treatment advantage was found.  Treatment effect size was moderated by 
attrition rates and end of treatment depression effect size.  
 
Conclusions: Findings suggest that CBT is an effective treatment for uncontrolled and 
excessive worry in older adults with GAD. Whilst comparable level of evidence is not 
available for other psychotherapeutic approaches, CBT should be routinely offered to 
older adults presenting to services with GAD. Future trials need to compare the relative 






•    CBT is an effective treatment and should be routinely offered to older adults    
      presenting with GAD. 
•    Services should explore group CBT as a front line treatment option for older adults  
     with GAD. 
•    Practitioners should use strategies to reduce attrition from treatment via addressing 






















Treatment of Generalised Anxiety Disorder (GAD) 
Generalised anxiety disorder (GAD) is a chronic and disabling condition 
(Revicki et al., 2012). It is the most common anxiety condition in older adults (aged 65 
and over), with reported prevalence rates ranging from 3.4% to 6.3% (Golden et al., 
2011; Wittchen et al., 2011). In older adults, GAD is associated with increased 
functional impairment (Brenes et al., 2005; Nabi et al., 2010; Porensky et al., 2009), 
cognitive impairment (Beaudreau & O’Hara, 2008, Mantella et al., 2007), reduced 
quality of life (Porensky et al., 2009; Wetherell et al., 2004), and increased service use 
(Porensky et al., 2009; Stanley et al., 2003a). High rates of comorbidity occur, 
particularly with depression – for which comorbidity rates as high as 60% have been 
reported (Wolitzky-Taylor, Castriotta, Lenze, Stanley, & Craske, 2010). The National 
Institute of Clinical Excellence (NICE) currently recommends pharmacotherapy, 
Cognitive Behavioural Therapy (CBT) or Applied Relaxation to treat GAD in adults 
(NICE, 2011). No specific recommendations have been made for older adult patients, 
due to lack of credible evidence. Given that services are frequently presented with older 
adults with GAD, review and synthesis of the evidence base is indicated (Gum, King-
Kallimanis, & Kohn, 2009). This review also provides contemporary guidance to 
clinicians concerning patient allocation and signposting.  
Older adults are found to prefer psychological therapy over medication for the 
treatment of anxiety conditions (Lenze et al., 2009; Mohlman, 2012). CBT is the most 
commonly researched psychotherapeutic treatment approach for GAD in older adults 
(Cuijpers et al., 2014). CBT for GAD contains aspects of cognitive structuring, 
exposure, and relaxation training (Barrowclough et al., 2001; Hofman, Asnaani, Vonk, 
Sawyer, & Fang, 2012). This treatment approach has gained popularity as more recent 
understanding of GAD has recognised uncontrolled and excessive worry as the key 





treatments for GAD in older adults have reported large treatment effects favouring 
psychotherapy (mainly CBT) in comparison to a passive control (Gonçalves & Byrne, 
2012; Gould, Coulson, & Howard, 2012). One review found a significant treatment 
effect in favour of CBT, when CBT was compared to active comparison groups for the 
treatment of a range of late-life anxiety disorders (Hendriks, Oude Voshaar, Keijsers, 
Hoogduin, & Balkom, 2008). However, this finding has not been replicated, and a 
number of subsequent reviews found no advantage for psychotherapies (mainly CBT) 
when compared to active comparison groups for the treatment of GAD (Gonçalves & 
Byrne, 2012; Gould et al., 2012). Studies also suggest that CBT for GAD may be less 
effective for older adults than it is for younger adults (Ayers, Sorrell, Thorp, & 
Wetherell, 2007; Covin, Ouimet, Seeds, & Dozois, 2008). Reasons posited include 
potential cognitive decline due to ageing and higher rates of psychiatric comorbidity 
(Mohlman, 2008; Wolitzsky-Taylor et al., 2010). There are a number of key 
weaknesses of this evidence base that warrant attention.   
First, existing reviews of CBT for GAD in older adults have tended to cover the 
range of psychotherapeutic treatment options (Gonçalves & Byrne, 2012), or CBT for 
the range of late-life anxiety disorders (Gould et al., 2012; Hendriks et al., 2008). The 
breadth of approaches included in previous reviews may have unwittingly masked 
apparent differences between specific psychotherapies and late-life anxiety conditions 
(Mohlman et al., 2004; Siev & Chambless, 2007). Second, previous reviews have 
predominantly measured effect sizes with respect to the treatment of GAD using a 
pooled anxiety composite. Unfortunately, this practice may have diluted treatment 
effects with respect to the hallmark feature of the condition, uncontrolled and excessive 
worry (APA, 2013). For this reason, in the measurement of GAD treatment effects, 
researchers are encouraged to use the Penn State Worry Questionnaire (PSWQ; Meyer, 





al., 2003). The PSWQ is a 16-item standardised measure of uncontrolled and excessive 
worry, validated for use in adults of all ages (Brown, Antony, & Barlow, 1992; Brown, 
Moras, Zinbarg, & Barlow, 1993; Crittendon & Hopko, 2006; Stanley, Novy, 
Bourland, Beck, & Averill, 2001; Wuthrich, Johnco, & Knight, 2014), as is it’s 
abbreviated version, the 8-item PSWQ-A (Hopko et al., 2003; Wuthrich et al., 2014). 
 Two published meta-analyses have focused on PSWQ effect sizes in 
evaluations of the effectiveness of psychological treatments for GAD (Covin et al., 
2008; Hanrahan, Field, Jones, & Davey, 2013). Hanrahan et al. (2013) focussed on 
cognitive therapy (CT) for GAD and excluded all older adult trials. Covin et al. (2008) 
included any adult, and older adult, trials in a review of CBT for pathological worry in 
GAD, the effect size for symptoms of pathological worry (as measured by the PSWQ) 
in the older adult trials was reported to be large (g = 0.82). However, the small number 
of trials (k = 4) included in the older adult subgroup analysis inflated the risk of 
positive selection bias. Furthermore, Covin et al. compared treatment effects across 
studies using a range of controls (i.e. both active and passive); mixing inappropriate 
groups in meta-analytic comparisons in this way can reduce the generalisability of 
findings (Wilson & Lipsey, 2001). Thus, there is a need to extend and expand the work 
of Covin et al. by including a greater number of older adult trials, alongside a number 
of pre-planned subgroup meta-analyses on the basis of control group subtype.  
The present study has therefore been prompted by identified methodological 
weaknesses of the existing evidence base for psychotherapeutic treatments for GAD in 
older adults. To enhance the quality of the evidence base, the present review included a 
greater number of older adult trials, did not report anxiety composite outcomes, 
performed pre-planned subgroup meta-analyses on the basis of control group subtype, 
and included a numbers-needed-to-treat (for one patient to expect additional benefit) 





symptom of GAD, uncontrolled and excessive worry, PSWQ/PSWQ-A outcomes were 
the focus of the meta-analysis. The main aim of the current meta-analysis was therefore  
to provide a robust examination of the efficacy of CBT for uncontrolled and excessive 
worry in older adults with GAD.  
 
Method 
 Preferred reporting items for meta-analyses systematic reviews and meta-
analyses (PRISMA) have been included as advised (Moher, Liberati, Tetzlaff, & 
Altman, 2009).  
Search Strategy 
Three electronic databases (PsychInfo, Web of Science, and ProQuest 
Dissertation and Theses) were searched from 01 Jan 1987 to 01 Nov 2015. The date 
that the DSM-III-R was published (1987) was the start date, as this was the first 
diagnostic manual to recognise GAD as a distinct disorder, characterised by excessive 
worrying (APA, 1987). The following title search string was used based on search 
terms used in related reviews (Gould et al., 2012; Gonçalves & Byrne, 2012): (GAD 
OR generalized anxiety disorder OR generalised anxiety disorder OR generalized 
anxiety disorder OR anxious OR anxiety OR worry) AND (older OR elder* OR geriat* 
OR late life OR late-life) AND (CBT OR cognitive behavioural therapy OR cognitive 
behavioral therapy OR treatment OR therapy). Reference lists of retrieved articles and 
prior reviews on the psychological treatment of late-life anxiety published in the last 10 
years were also searched manually to identify potentially eligible studies.  
Eligibility Criteria 
Studies included were required to meet the following criteria. First, participants 
were required to have been at least 55 years, with a mean age of >65 years, and a 





participants were required to have a principal or co-principal diagnosis of GAD, as per 
the Gonçalves and Byrne (2012) review of interventions for GAD in older adults.  
Next, studies were required to have used a randomised controlled trial (RCT) 
design. One study arm was required to have included a psychological intervention that 
involved all three core components of CBT for GAD: psycho-education, cognitive 
restructuring, and exposure to anxiety-provoking situations (Borkovec, Newman, 
Pincus, & Lytle, 2002). Studies were required to have included comparison group data 
for participants that did not immediately receive CBT for GAD.  
Studies were also required to have used the PSWQ or the PSWQ-A as an 
outcome measure. In studies in which a composite anxiety score was reported, 
PSWQ/PSWQ-A outcome data needed to be available from the authors on request. In 
the case of multiple articles reporting on the same data set, the study with the largest 
sample size, or that was most relevant to the aims of this review, was selected.  
All studies were also required to have been published in English. 
Data Extraction 
An a priori data extraction coding frame was developed. Studies were coded for 
a number of trial and practice factors including control group subtype (waitlist control 
group [WCG], treatment-as-usual [TAU], or active treatment [AT]) and treatment 
mode (individual or group). Clinical variables extracted included mean baseline 
PSWQ/PSWQ-A and depressive symptomology scores. These were converted to 
standardised z-scores, due to the different measures used for each variable across 
studies (Gallagher, Nies, & Thompson, 1982; Segal, Coolidge, Cahill & Riley, 2008; 
Wuthrich et al., 2014). Dropout rate was calculated for CBT as: (CBT dropouts from 
point of randomisation to the end treatment/total number of participants randomised to 
CBT) x 100. This was repeated for control conditions. Overall attrition rate for each 





treatment + control dropouts at the end of treatment)/total number of eligible 
participants prior to randomisation] x 100. Treatment response data was extracted from 
articles in which it was provided. The percentage of treatment responders was 
calculated using an intention-to-treat analysis (ITT), and those that dropped out were 
classified as non-responders (Hollis & Campbell, 1999). Percentage of treatment 
responders was therefore calculated as follows: (number of treatment responders 
reported/total number of participants randomised to each study arm) x 100. 
Within-Study Quality and Risk of Bias 
The methodological quality assessment tool used (Appendix A) was designed 
by the Cochrane Common Mental Disorders Anxiety and Neurosis Group (CCDAN; 
Moncrieff, Churchill, Drummond, & McGuire, 2001). The CCDAN was selected as it 
has been used in the extant literature, enabling comparison with results obtained herein 
(Gonçalves & Byrne, 2012). Higher scores on this 23-item measure indicate studies of 
greater methodological quality (scores range from 0 to 46). The quality of each study 
was rated independently by three raters (two qualified clinical psychologists, and one 
trainee clinical psychologist). Two of the three raters were blind to study author(s), year 
of publication, and journal. Fleiss’ kappa was used to assess interrater reliability, as 
there were more than two raters and ratings were categorical (Fleiss, 1971).  
The sole use of quality rating scales has been criticised by the Cochrane group 
because summary scores necessarily involve arbitrarily weighting items (Higgins & 
Green, 2011a). For this reason, the Cochrane Risk of Bias Tool was also used in the 
present review to facilitate the assessment of within-study bias (see Appendix B; 
Higgins et al., 2011b). For each area of the seven areas of potential bias, studies were 







Between-Group Effect Sizes   
Effect sizes corresponded to the standardised difference between the CBT 
treatment group and control group (Dobson, 1989). Between-group treatment effect 
sizes at end of treatment were calculated as follows: (CBT group end of treatment score 
– control group end of treatment score)/pooled SD (Borenstein, Hedges, Higgins, & 
Rothstein, 2009). Effect sizes were based on completers-only data, as this was the data 
that was available in 8/14 of the studies included. As a number of trials had small 
samples, effect sizes were corrected using an adjustment, J , to convert effect sizes to 
Hedges’ g (Hedges, 1981). A formula for calculating an approximation of J described 
by Borenstein et al. (2009) was applied, J = 1 – (3/4df – 1).  
Meta-analyses assume each study is independent, so it was important that each 
study contributed no more than one between-groups effect size to each analysis 
(Brewin, Kleiner, Vasterling, & Field, 2007). Thus, in studies in which multiple 
treatment arms received CBT, where treatment was comparable, data was collapsed to 
form a combined CBT group (Mohlman & Gorman, 2005; Stanley et al., 2014). In the 
Wetherell et al. (2013) trial treatments received by the two CBT groups were not 
considered comparable, therefore data from the CBT group most relevant to this review 
was extracted (CBT plus escitalopram). In the Mohlman (2008) study, the waitlist data 
(8-week) from the group that received augmented CBT was used as the control, and 
compared against the 8-week CBT data from the other treatment arm. For studies in 
which there were multiple comparison groups that did not receive CBT, data from the 
control group that had received the most active comparison condition was extracted 
(Wetherell, Craske, & Gatz, 2003; Wetherell et al., 2013). This enabled a more 
conservative estimate of population effect size, given that passive controls often result 







SPSS macros developed by Wilson (2005) were used to compute random-
effects meta-analyses; there were a number of advantages to this. First, random-effects 
models prevent strong assumptions about the population thus providing a more realistic 
estimate of the pooled mean effect size (Borenstein et al., 2009). Second, between-
study heterogeneity was anticipated (Gonçalves & Bryne, 2012), and random-effects 
models increase the generalisability of findings in which a degree of between-study 
heterogeneity is observed (Borenstein et al., 2009).  
In the random-effects meta-analysis model used, weighted average effect sizes 
(g) were calculated from the sum of the inverse within-study variance (W= 1/Vg) and 
the between-study variance (Jackson, Bowden, & Baker, 2010). First, the within-study 
variance of g was computed for each study in turn (Vg), using the formula described by 
Borenstein et al. (2009). Inverse within-study variance was used in order that studies 
with increased levels of variability (and thus lower precision) were given less 
weighting in the overall effect size estimate computed. Second, between-study variance 
was calculated using the restricted maximum likelihood (REML) method (Raudenbush, 
2009). REML is more sensitive in meta-analyses using small sample sizes (Jackson et 
al., 2010), an anticipated feature of this review given the extant literature (Gonçalves & 
Byrne, 2012). Lastly, the sum of the product of all effect sizes and weights was divided 
by the sum of all weights in order to derive an overall sample-weighted population 
effect size estimate (Borenstein et al., 2009).  
Mean effect sizes obtained were reversed. Thus a positive effect of CBT was 
represented by a positive effect size, and vice-versa (Borenstein et al., 2009). The 
threshold for statistical significance was an alpha value of 0.05, based on statistical 
norms found in the majority of research published (Borenstein et al., 2009). The 





0.20‒0.49 = small, 0.50‒0.79 = medium, and >0.80 = large. Effect sizes obtained were 
also interpreted on the basis of findings from meta-analyses that had assessed the 
effects of CBT on pathological worry in GAD for younger adults (Covin et al., 2008; 
Hanrahan et al., 2013). Meta-analyses assessed pooled mean effects sizes for end of 
treatment and 6-month follow-up data. Subgroup meta-analyses were pre-planned on 
the basis of anticipated heterogeneity between control subgroups (i.e. WCG, TAU, and 
AT; Gonçalves & Byrne, 2012; Hanrahan et al., 2013).  
Effect sizes were also translated into NNTB (Altman & Andersen, 1999; 
Higgins & Green, 2011a; Cook & Sackett, 1995). This procedure is recommended in 
order to provide a clinically relevant interpretation of standardised treatment effect 
sizes (Kraemer & Kupfer, 2006). The method described by Kraemer and Kupfer (2006) 
for calculating NNTB was used. Accordingly, unadjusted effect sizes (Cohen’s d) were 
converted to the corresponding area under the curve statistic (AUC) (Ruscio, 2008), 
and then NNTB was calculated using the following formula: 1/(2xAUC – 1) (Kraemer 
& Kupfer, 2006).  
Moderator Analyses 
Moderator analyses were pre-planned based on the extant literature (Gonçalves 
& Byrne, 2012; Hanrahan et al., 2013; Hendriks et al., 2008). Two categorical variables 
(control type and treatment mode) were assessed in turn using the using the METAF 
macro for SPSS (Wilson, 2005). This macro computes the analog to a one-way analysis 
of variance. The presence of a moderator was indicated by a statistically significant 
homogeneity Q statistic. Nine continuous variables were assessed through a series of 
random-effects univariate meta- regressions using the METAREG macro for SPSS 
(Wilson, 2005): age (mean), females (%), attrition rate (%), number of CBT sessions, 
baseline co-morbid psychiatric diagnoses (%), baseline depression diagnoses (%), mean 





or PSWQ-A), baseline depression symptoms (standardised z-scores due to range of 
measures), and pre- to post-treatment depression effect size (Hedges’ g). For each 
meta-regression, significant moderators of PSWQ/PSWQ-A effect size were indicated 
by a statistically significant beta value of p <.006 (.05/9), based on a Bonferroni 
Adjustment to the significance level due to multiple univariate testing (Higgins & 
Thompson, 2002). Depression effect sizes at end of treatment were also calculated in 
order to test their potential as moderators of PSWQ effect size. As guidance suggests 
meta-regression should not be used where there are <10 studies, moderator analyses 
were not conducted for each control subgroup, or 6-month follow-up data (Higgins & 
Green, 2011a). 
Analysis of Statistical Heterogeneity 
The Q-statistic (Higgins & Thompson, 2002; Higgins, Thompson, Deeks, & 
Altman, 2003) enabled unexplained statistical heterogeneity between studies to be 
detected. A significant Q-value resulted in the rejection of the null hypothesis of 
homogeneity. Due to the small number of studies (k <10) included in sub-group and 6-
month follow-up analyses, a p-value of .10 was used (Higgins & Green, 2011a). The I
2
 
statistic was computed as an indicator of the ratio of true statistical heterogeneity to the 
total variation in observed effects (Higgins et al., 2003). A rough guide to the 
interpretation of I
2
 values has been proposed: 0‒40% might not be important, 30‒60% 
may represent moderate heterogeneity, 50‒90% may represent substantial 
heterogeneity and 75‒100% considerable heterogeneity (Higgins et al., 2003). The 
interpretation of I
2 
values should also be based on: a) the magnitude and direction of 
effect size, and b) the evidence for heterogeneity, such as the associated p-value 







Reporting Bias   
In order to assess for between-study reporting bias, a funnel plot provided a 
graphical representation of the relationship between the standard error of included 
studies and their effect sizes (Sterne, Egger, & Smith, 2001). In the absence of 
reporting bias, a symmetrical distribution of studies around the pooled mean effect size 
(resembling an inverted funnel) would be observed. Straight lines were drawn to 
indicate the area in which 95% of studies would be expected to be found in the absence 
of heterogeneity and reporting bias. 
The assessment of bias solely on the basis of the visual inspection of a funnel 
plot has been criticised (Terrin, Schmid, & Lau, 2005). Thus, two additional statistical 
methods were used to detect publication bias. First, the funnel plot regression method 
was used which is a regression test based on sample size and for which a significant 
beta value would be considered indicative of publication bias (Macaskill, Walter, & 
Irwig, 2001). Second, Rosenberg’s fail-safe N test was used to indicate the number of 
additional negative studies needed to increase the p-value of the meta-analyses to above 
.05 (Rosenberg & Goodnight, 2005). The findings from Rosenberg’s test were 
considered cautiously, given the test’s emphasis on the significance of an arbitrary p-
value (Higgins & Green, 2011a).  
 
Results 
Study Selection  
The initial search resulted in 428 potentially relevant titles (see Figure 1), of 
which 273 titles remained after duplicates had been removed. A further 132 papers 
were excluded on the basis of the study abstract for the following reasons: medication 
trial (n = 49), review (n = 28), child/working-aged adults (n = 17), or other e.g. editorial 





excluded on the following basis: 75% of participants did not have a principal or co-
principal diagnosis of GAD (n = 50), no intervention (n = 35), uncontrolled design (n = 
16), non-CBT intervention (n = 14), sample did not have a mean age of >65 years (n = 
6), or the absence of the PSWQ/PSWQ-A as an outcome measure (n = 3). Two of the 
remaining 17 studies (Barrera et al., 2015; Wetherell, 2001) were excluded because 
they included duplicate data from more appropriate eligible articles (Stanley et al., 
2014; Wetherell et al., 2003). Lastly, one study was excluded because raw end of 
treatment PSWQ data was not available from the author on request (Mohlman et al., 
2003). Fourteen original RCTs met all the inclusion criteria and so were included in 
this review. The total N across the trials was 985 and the average age of older adults 
with GAD was 68.16 years (SD = 2.52). 
 







Table 1 summarises the 14 RCTs included in this meta-analysis. Studies are 
organised by control subgroups: waitlist control group [WCG], treatment-as-usual 
[TAU], and active treatment [AT]. Within each control subtype category trials have 
been ordered by quality ratings, highest rated studies first. All trials were community-
based. However, there was heterogeneity between the studies with respect to trial 
factors. For example, sample sizes ranged from 8 to 223 (M = 70.36, SD = 59.99), and 
although on average 68% of participants were female this ranged between 48% and 
84%. The majority of studies (9/14) compared CBT against a passive control condition. 
Participants in all three WCG trials were recruited via advertising and assumed not to 
be in contact with services during the wait period. TAU participants received 
treatments of varying intensity, and in 4/6 studies participants received enhanced care 
which included: weekly phone calls (Stanley et al., 2003b; Stanley et al., 2003c), 
biweekly phone calls (Stanley et al., 2009), and weekly 10–15 mins medication 
management sessions (Gorenstein et al., 2005). In the five AT studies, control group 
participants received the following interventions: non-directive psychotherapy (Stanley, 
Beck, & Glassco, 1996), a discussion group (Wetherell et al., 2003), acceptance and 
commitment therapy (Wetherell et al., 2011), telephone-delivered non-directive 
supportive therapy (Brenes, Danhauer, Lyles, Hogan, & Miller, 2015), and 
escitalopram (Wetherell et al., 2013).  
On average, one-fifth of CBT participants (20%) dropped out of treatment 
before completion (range 0–44%). Follow-up data was sparse, with less than half of 
studies (5/14) presenting 6-month follow-up data (treatment-free) for both CBT and 
comparison group. Between-study heterogeneity was evident in terms of practice 
factors. For instance, although individual CBT was most commonly delivered (9/14 





the average length of CBT delivered was 11.79 weeks (SD = 2.39), it ranged from 8 to 
16 weeks. CBT was generally delivered face-to-face (11/14 studies), except for two 
trials which involved telephone delivery (Brenes, Ingram, & Danhauer, 2012; Brenes et 
al., 2015). In the Stanley et al. (2014) trial, for which the data from the CBT arm was 
collapsed, CBT was delivered to 51% of CBT participants by ‘lay providers’ (bachelor-
level students).  
Rates of comorbidity were high. On average, over half of participants (60%) 
met criteria for at least one other psychiatric diagnosis (range 39–80%) and a third of 
participants (32%) had a diagnosis of a depressive disorder (range 17–47%). Two 
studies (Mohlman & Gorman, 2005; Mohlman, 2008) excluded participants with major 
depressive disorder though included participants with dysthymia (25% of each sample).  
Three trials provided no definition of treatment response (Brenes et al., 2012; 
Wetherell et al., 2009; Wetherell et al., 2011), with the remaining 11 studies providing 
inconsistent definitions. No study stipulated that a reliable and clinically significant 
change in symptoms of uncontrolled and excessive worry was required for participants 
to be considered a treatment responder.  
Of studies reporting a definition of treatment response, based on ITT response 
rates, almost half of CBT participants (45%) were found to recover (range 19–83%). 
Average ITT response rates indicated few WCG participants recovered (2%), around a 
fifth recovered during TAU (23%), and two-fifths of participants recovered following 
AT (38%).  
Study Quality and Bias 
Overall quality ratings were out of 46 (higher scores represented papers rated as 
higher quality) and the average quality rating was 33.57 (SD = 5.68). The quality of the 





three control subgroups, though more varied for TAU studies: WCG (M = 33.00, SD = 
3.61), TAU (M = 33.67, SD = 7.69), and AT (M = 33.80, SD = 4.92).  
Across many of the domains assessed, studies demonstrated high quality levels: 
clearly described outcome measures (14/14 studies), full description of participant 
demographics (12/14), assessment of treatment compliance (13/14), and adequate 
presentation of results for re-analysis (13/14). The quality domains rated lower in a 
number of studies included: full details of side effects of treatment profile by group 
(1/14 studies), power calculation (4/14), and adequate sample size (9/14). Excellent 
inter-rater reliability was observed (κ = 0.99; 95% CI95: 0.94, 1.03) and the three raters 
disagreed on just four quality assessment items across the 14 papers (Appendix C). 
Some risk of within-study bias was indicated for all papers (Appendix D). For 
example, although allocation to conditions was described as random in all studies, just 
6/14 provided adequate details of the process of random sequence generation indicating 
potential risk of selection bias. Also, risk of performance bias was apparent in 7/14 
studies in which assessor blinding and/or the testing of the integrity of assessor blinding 
was not reported. TAU studies were generally deemed at the lower risk of bias than 
WCG or AT studies, with the exception of the Stanley et al. (2003c) TAU paper which 
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Between-group random effects meta-analyses were conducted for end of 
treatment and 6-month follow-up PSWQ/PSWQ-A data. Control subgroup meta-
analyses were conducted at each time-point.   
End of Treatment Analyses 
CBT vs. any control. For all 14 primary studies (completer n = 772), the end of 
treatment population effect size estimate for CBT compared to any control was medium 
in favour of CBT, g = 0.66 (CI95: 0.42, 0.90), and significant (z = 5.48, p <.001). Figure 
2 (plot d) displays the corresponding forest plot. Significant statistical heterogeneity 
and substantial between-study inconsistency were found (Q(13) = 28.67, p = .001, I
2 
= 
55%, v = 0.10), which indicated significant variance in effect size distribution and 
further justified the use of a random-effects meta-analysis.  
CBT vs. waitlist control group (WCG). The population effect size estimate 
for CBT compared to WCG (k = 3, n = 86) was a large effect size in favour of CBT, g 
=1.10 (CI95: 0.38, 1.82), and significant (z = 3.01, p <.01). Figure 2 (plot a) displays the 
corresponding forest plot. The assumption of homogeneity was violated (based on the 
significance level of p < 0.1 adopted for subgroup analyses), and substantial 
inconsistency was found between studies (Q(2) = 5.38, p = .07, I
2 
= 63%, v = 0.25). 
CBT vs. treatment-as-usual (TAU). For CBT compared to TAU (k = 6, n = 
444), the population effect size was medium and in favour of CBT, g = 0.67 (CI95: 0.36, 
0.98), and significant (z = 4.22, p <.001). Figure 2 (plot b) displays the corresponding 
forest plot. The assumption of statistical homogeneity was violated and moderate 
between-study inconsistency was indicated (Q(5) = 9.67, p = .09, I
2 
= 48%, v = 0.07). 
CBT vs. active treatment (AT). When CBT was compared to AT (k = 5, n 
=242) the population effect size was small, g = 0.42 (CI95: -0.05, 0.89), and non-





AT studies violated the assumption of statistical homogeneity, and substantial 
inconsistency between studies was observed (Q(4) = 11.53, p =.02, I
2
















Figure 2. End of treatment and 6-month follow-up forest plots of PSWQ/PSWQ-A: Hedges’ g. 
Forest plots show standard errors (SE), confidence intervals (95% CI), and inconsistency of 
study findings (I
2
), for CBT vs. control conditions (a‒g). Note. WCG = waitlist control group; 









CBT vs. any control. The population effect size for CBT compared to any 
control group (k = 5, n = 238) at 6-month follow-up, was in the small-to-medium range 
in favour of CBT, g = 0.46 (CI95: 0.07, 0.85), and significant (z = 2.28, p =.02). See 
Figure 2 (plot g) for the corresponding forest plot. Studies violated the assumption of 
statistical homogeneity (given the significance level p <0.1 adopted for follow-up 
analyses), and between-study inconsistency was substantial (Q(4) = 8.24, p = .08, I
2 
= 
51%, v = 0.10). 
CBT vs. passive controls. Due to the paucity of passive control studies that had 
6-month control follow-up data, WCG and TAU studies were considered as a single 
subgroup. The 6-month follow-up population effect size estimate for CBT compared to 
passive controls (k = 2, n = 170) was large and in favour of CBT, g = 0.83 (CI95: 0.52, 
1.14), and significant (z = 5.21, p <.001). Figure 2 (plot e) displays the corresponding 
forest plot. Between-study statistical homogeneity was found (Q(1) = 0.03, p = .86, I
2 
= 
0%, v = 0.00). 
CBT vs. active treatment (AT). The 6-month follow-up population effect size 
estimate for CBT compared to AT (k = 3, n = 68) was near zero, g = 0.06 (CI95: -0.37, 
0.49), and non-significant (z = 0.28, p = .78). Thus, at follow-up no advantage was 
found for either CBT or AT, with the corresponding forest plot displayed in Figure 2 
(plot f). The assumption of statistical homogeneity was satisfied (Q(2) = 0.19, p = .91, 
I
2 
= 0%, v = 0.00). 
Numbers-Needed-To-Treat (NNTB) 
Table 2 reports the NNTB illustrating a range from 2 to 30 patients. At post-
treatment, 1 in 2 patients would be expected find additional benefit from CBT when 
compared to a WCG. However, when compared to AT, at the end of treatment, just 1 in 







Moderator Analyses    
Control subtype (WCG vs. TAU vs. AT) did not significantly moderate 
PSWQ/PSWQ-A effect size (Q(2) = 2.89, p = .24), nor did treatment format (group vs. 
individual) (Q(1) = 0.77, p = .38). However, attrition rate was found to significantly 
moderate PSWQ/PSWQ-A effect size (z = -2.89p =.0039), and studies with 
lower attrition rates were found to report significantly greater PSWQ/PSWQ-A effect 
sizes in favour of CBT. Baseline to end of treatment depression treatment effect sizes 
also moderated PSWQ/PSWQ-A effect size (z = 2p = .0057). Thus, in 
studies in which CBT treatment gains for symptoms of depression were greater, 
associated PSWQ/PSWQ-A treatment gains were also significantly greater. None of the 
remaining variables assessed (including treatment length or format) were found to 
significantly moderate PSWQ/PSWQ-A effect size, given the significance value of p 
<.006 adopted.  
Reporting Bias 
The distribution of the 14 studies around the pooled mean effect size was 
slightly asymmetrical indicating some risk of systemic reporting bias (See Figure 3). 
The funnel plot regression method did not indicate the presence of significant reporting 
bias, -0t(13) = -0.63, p = .54 (Macaskill et al., 2001). The fail-safe N 





present findings would be 213 for a fixed-effects model and 12 for a random-effects 
model (Rosenberg & Goodnight, 2005). These findings generally indicated that the 
overall population effect size estimate was likely to be relatively robust.  Funnel plots 
were not drawn out for control subgroup analyses or 6-month follow-up data, as it is 























Figure 3. Funnel plot of end of treatment PSWQ/PSWQ-A Hedges’ g effect sizes  
plotted for all 14 primary studies. Note. WCG = waitlist control group; TAU = treatment 
-as-usual; AT = active treatment. 
 
Discussion 
This review examined treatment effects of CBT for older adults with GAD in 
terms of uncontrolled and excessive worry and extends the preliminary analysis 
reported by Covin et al. (2008). The inclusion of more trials and greater analytic 
specificity has increased the generalisability of the results found. In comparison to 
allocation to a waiting list, CBT was found to produce a large effect with respect to 
uncontrolled and excessive worry symptoms immediately post-treatment. The NNTB 





additional benefit when compared to being on a waiting list. Results of CBT in 
comparison to TAU found there to be medium treatment effects in favour of CBT. At 
6-month follow-up, large effects in favour of CBT were observed in comparison to 
passive controls. The associated NNTB obtained suggested that every other patient 
would be expected to benefit from CBT at 6-month follow-up. These findings 
combined would suggest that when compared to having no treatment at all (or TAU), 
CBT is an effective treatment for symptoms of uncontrolled and excessive worry in 
older adults with GAD.  
Comparisons of CBT vs. AT for GAD were less encouraging. Results suggested 
small comparative post-treatment gains for CBT over AT, and no treatment advantage 
for CBT at 6-month follow-up. However, AT studies included in follow-up analyses 
included just 68 participants, which reduced the power of this subgroup analysis. Only 
one trial compared CBT to an extant treatment, the Wetherell et al. (2011) paper in 
which CBT was compared to acceptance and commitment therapy. For this reason, this 
review has not been able to comment on the relative efficacy of CBT for uncontrolled 
and excessive worry compared to other evidence-based psychotherapies. The 
generalisability of the Wetherell et al. (2011) trial was unfortunately limited by the 
small sample size (n = 21). 
Moderators of Worry Treatment Effects  
Moderator analyses showed that CBT treatment effects for worry were 
significantly moderated by treatment effects for depression symptoms, specifically that 
greater CBT treatment effects for depression were associated with greater CBT 
treatment effects for worry. These findings highlight a useful avenue for further 
research given current interest in transdiagnostic approaches for the treatment of 
comorbid anxiety and depression (Wilamowska et al., 2010; Wuthrich, Rapee, Kangas, 





Attrition rates also significantly moderated PSWQ/PSWQ-A effect sizes such 
that higher CBT attrition rates were associated with reduced CBT treatment effects for 
worry. Moreover, as completer-only analyses were conducted this finding has likely 
under-estimated the extent to which attrition moderated worry outcomes for all eligible 
trial participants (including dropouts before, or after, randomisation). This finding has 
highlighted the importance of acceptability and feasibility work in the early stages of 
the development of new therapies in order to reduce attrition (Salkovskis, 1995).  
Comparisons with the Extant Literature 
Findings from this review were broadly in line with the preliminary analyses 
presented by Covin et al. (2008). However, in the comparison of CBT and any control 
condition (passive or active), Covin et al. reported an effect size of greater magnitude 
(g = 0.82). There are a few possible reasons for this difference. First, the Covin et al. 
review included fewer studies, which increased the risk of positive selection bias. 
Second, Covin et al. used passive control data from the Wetherell et al. (2003) study in 
between-group analyses, whilst active control data from the trial was used in this 
review.  As outlined previously, it has been suggested that passive controls can inflate 
population effect size estimates (Gallin & Ognibene, 2012).  
The present study also adds weight to the suggestion by Covin et al. (2008) that 
CBT for symptoms of uncontrolled and excessive worry in GAD is less effective for 
older adults than for younger adults. In a subgroup meta-analysis of younger adult 
studies, Covin et al. found an overall mean of g = 1.69 in favour of CBT for 
pathological worry in a comparison between CBT and any control condition. 
Furthermore, in a meta-analysis of CT for worry (in which older adult studies were 
excluded), Hanrahan et al. (2013) reported an effect size of g = 0.93 in favour of CT, in 






Limitations and Further Research 
The present review has a number of limitations. The selection criteria was 
stringent in order to ensure that studies included were of a sufficiently high quality to 
permit useful conclusions to be drawn. However, a number of the studies included were 
found to have significant risk of bias in a number of areas (e.g. random sequence 
generation was only described in 6/14 trials). There were also relatively few studies 
containing sufficient follow-up data and this increased the risk of positive selection bias 
and an inflated effect size estimate. Future studies with longer between-group follow-
up periods (with larger samples) are required.  
There was heterogeneity between primary studies with respect to trial and 
practice variables, such that percentage of women included in each trial ranged from 
48% to 84%, and CBT duration ranged between 8 and 16 sessions. Heterogeneity was 
also present within control subgroups, for example, the intensity of TAU varied from 
scheduled weekly contact (Gorenstein et al., 2005; Stanley et al., 2003b; Stanley et al., 
2003c) to primary healthcare provision as usual (Stanley et al., 2014; Wetherell et al., 
2009). However, moderator analyses suggested trial and practice variables assessed did 
not significantly moderate PSWQ/PSWQ-A treatment effect sizes, with the exception 
of attrition rates, increasing the generalisability of findings. However, a number of the 
meta-analyses violated the assumption of statistical homogeneity reducing the 
generalisability of findings. This may have reflected that a number of the trials 
available to analyse were small studies, which may have potentially introduced ‘small-
study effects’; a trend for smaller studies to show larger treatment effects and so to 
positively bias results (Sterne, Gavaghan, & Egger, 2000). Incomplete outcome data 
also meant completers-only effect size estimates were computed, which may have led 





order that a more conservative estimate of worry treatment effects can be considered 
(Hollis & Campbell, 1999).  
Lastly, the present review has focussed solely on outcomes with respect to 
uncontrolled and excessive worry (as measured by self-report measures, the PSWQ or 
PSWQ-A). This reliance on self-report measures of worry may have weakened the 
review findings. For example, Steer, Beck, Clark, and Ranieri (1995) found that PSWQ 
scores did not significantly correlate with clinician ratings of GAD severity. However, 
this was not a consistent finding and a subsequent study by Hopko et al. (2000) found 
clinician-rated GAD severity correlated significantly with PSWQ scores. Nevertheless, 
future trials are encouraged to include clinician-rated GAD outcomes to strengthen the 
validity and reliability of outcomes analysed. The anxiety disorders interview schedule 
(ADIS-IV; Brown & Barlow, 2014) is a valid clinician rated GAD measure which does 
assess worry. 
Clinical Implications 
 In an analysis of gold standard trials, CBT has been found to be an effective 
treatment for uncontrolled and excessive worry in older adults with GAD. This is a 
level of evidence that is not currently available for other psychotherapeutic approaches 
in the treatment of GAD, and indicates that CBT should be routinely offered to older 
adults presenting to services with GAD. Treatment outcomes were not moderated by 
delivery mode (group vs. individual) or treatment length. Given the cost savings 
offered by group delivery and briefer interventions, these findings represent an 
opportunity for services to consider group CBT as a front line treatment option 
(Department of Health, 2011).  
That said, this study adds to evidence that suggests that CBT for symptoms of 
uncontrolled and excessive worry in GAD may be less effective for older adults than 





efficacy of CBT provided to older adults with GAD through the consideration of novel 
approaches such as the age-appropriate augmentation of CBT (Laidlaw & Kishita, 
2015). Clinicians should also consider the implementation of evidence-based strategies 
to reduce attrition such as pre-therapy work to address assumptions about 
psychotherapy or motivational interviewing (Barrett, Chua, Crits-Christoph, Gibbons, 
& Thompson, 2008).  
 
Conclusion 
The main objective of this review was to consider the efficacy of CBT for the 
treatment of older adults with GAD. Previous reviews of CBT for GAD in older adults 
have considered the effectiveness of CBT for GAD on the basis of an anxiety 
composite, obscuring treatment effects for uncontrollable and excessive worry which is 
the hallmark feature of GAD. In response to identified methodological weaknesses of 
the extant literature, the present review considered CBT outcomes for GAD using two 
validated measures of excessive and uncontrollable worry (PSWQ/PSWQ-A). In doing 
this, the present review has been able to demonstrate that CBT is an effective treatment 
for uncontrolled and excessive worry symptoms in older adults with GAD. This review 
therefore represents an important contribution to outcome research on CBT for older 
adults with GAD.  
Findings provide support for the ongoing use of CBT for the treatment of 
uncontrolled and excessive worry in older adults with GAD. However, results do not 
provide evidence that CBT is more effective than other active psychological 
interventions. In order for the relative efficacy of CBT for GAD to be assessed, there is 
a need for further ‘head-to-head’ RCTs. Researchers need to use longer follow-up 
periods for both treatment and control arms in order that the durability of treatment 





lower worry treatment effects, findings also highlight the importance of treatment 
acceptability. In conclusion, older adults with GAD should not be discarded as ‘life-
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Appendix A. CCDAN Quality Assessment Tool (Moncrieff et al., 2001) 
 
























Appendix A. CCDAN Quality Assessment Tool (continued; Moncrieff et al., 2001) 
 
 























Appendix B. Cochrane Risk of Bias Tool (Higgins & Green, 2011) 
 
























Appendix C. Interrater Reliability Fleiss’ kappa 


















































































































1 36 34 
 
29 33 35 20 38 41 36 40 30 36 28 32 
2 36 35 29 33 35 19 38 41 36 40 32 36 30 32 
3 36 34 29 33 35 19 38 41 36 40 34 36 26 32 
Total number of rating items (k = 14 x 23) = 322 (scores 0-2) 
 N of items for which there was total agreements = 318 items 
N of items at least two of the raters disagreed = 4 items 





















Appendix D. Bias Summary Table 
 






































Part Two: Research Report 
 
An evaluation of the acceptability, feasibility, and effectiveness of an existing 








































Objective. To evaluate an existing generalised anxiety disorder (GAD) treatment 
protocol in a group delivery format with older adults. 
 
Design. A case series with an A-B design with follow-up was used to assess feasibility, 
acceptability, effectiveness, and potential change mechanisms across three study 
phases: baseline, intervention, and follow-up. Mixed methods enabled the triangulation 
of findings for convergence and complementarity purposes.  
 
Methods. Eligible participants (N = 23) were required to have a clinical diagnosis of 
GAD, and were recruited through primary care and community mental health services. 
The adapted GAD protocol was delivered over 12 weeks.  Participant outcomes were 
measured using the PSWQ, GAD-7, PHQ-9, IUS, and a daily worry diary. At the end 
of treatment, completer change interviews and facilitator focus groups were conducted. 
Mixed outcomes were merged using a triangulation protocol. 
 
Results. Opt-in and dropout rates, alongside feedback (participant and facilitator), 
indicated that group delivery of the worry protocol was acceptable and feasible. Large 
PSWQ treatment effect sizes were found at the end of treatment and follow-up.  A 
medium treatment effect size for depression was found at follow-up. Change 
mechanism findings suggested that addressing intolerance of uncertainty may have 
contributed to treatment gains. 
 
Conclusion. The adapted GAD treatment protocol was found to be a feasible, 





shows real promise as a treatment for GAD in older age and further controlled studies 
against other active treatments are warranted.  
 
Practitioner Points 
 Group CBT appears an acceptable and effective treatment option for older 
adults with GAD. 
 Older adults with co-morbid depression can still benefit from CBT for their 
GAD. 
 GAD treatment protocols should consider session pacing, inclusion of more 






















Prevalence rates of generalised anxiety disorder (GAD) in older adults are 
estimated to be between 3.4% and 6.3% (Allgulander, 2006; Golden et al., 2011; 
Wittchen et al., 2011). GAD is, however, ‘frequently missed’ as a disorder by services 
due to factors such as comorbidity, medication use, and functional status (Ayers, 
Sorrell, Thorp, & Wetherell, 2007). For those who do receive a diagnosis, chronicity is 
an issue as around 90% of older adult GAD sufferers are diagnosed before the age of 
60 years (Grant et al., 2005).  
In the treatment of GAD, older adults prefer psychological therapy to 
medication (Mohlman, 2012). The National Institute for Health and Care Excellence 
(NICE) recommends cognitive behavioural therapy (CBT) and applied relaxation for 
the non-pharmacological treatment of GAD in adults (NICE, 2011). No specific 
recommendations are made for older adults due to a lack of credible evidence, though 
reviews suggest that CBT for GAD may be less effective for older adults than it is for 
younger adults (Covin, Ouimet, Seeds, & Dozois, 2008; Wolitzy-Taylor, Castriotta, 
Lenze, Stanley, & Craske, 2010). Reasons suggested include age-related cognitive 
impairment, high rates of comorbidity with depression, and difficulties with attendance 
due to physical comorbidities (Brenes, Ingram, & Danhauer, 2012; Mohlman 2008; 
Wuthrich & Rapee, 2013). Moreover, CBT for GAD in older adults may be only 
marginally more effective than active treatment control conditions (Gonçalves & 
Byrne, 2012; Gould, Coulson, & Howard, 2012; Hall, 2016). There is clearly a need to 
develop the GAD older adult evidence base. 
The rising costs of mental health provision for older adults, as a result of 
increased life expectancy, have led to increased focus on the provision of cost-effective 
psychological treatments for this cohort (McCrone, Dhanasiri, Patel, Knapp, & 





effectiveness of treatment (Kwon & Oei, 2003). Non-specific benefits of group CBT 
include peer support, reduced social isolation, and shared empathy (Krishna et al., 
2011; Lewinsohn & Clarke, 1999; Morrison, 2001; Yalom & Leszcz, 2005). These 
factors may be particularly relevant for older adults, given an increased risk of 
loneliness in those aged over 75, which has been associated with significant reductions 
in mental wellbeing (Capezuti, Boltz, & Renz, 2004; Dykstra, 2009; Hawkley & 
Cacioppo, 2010).  
To date, trials of group CBT for older adults with GAD have reported 
conservative findings. Stanley et al. (2003) reported significant treatment effects in 
favour of group CBT when compared to usual care. However, in trials using active 
control groups, CBT has been found to be only marginally more effective than non-
specific group psychotherapies (Stanley, Beck, & Glassco, 1996; Wetherell, Gatz, & 
Craske, 2003). Furthermore, Schuurmans et al. (2009) found sertraline to have a more 
significant treatment effect on worry symptoms than group CBT. However, much of 
the evidence base for group CBT for older adults with GAD does not reflect recent 
innovations in treatment approach based on trial evidence in younger adult samples 
(e.g. Dugas et al., 2010; Wells et al., 2010).  
Cognitive treatments for GAD have received recent attention as excessive and 
difficult to control worry has gained recognition as the hallmark feature of GAD 
(American Psychiatric Association [APA], 2013). Treatment protocols have been 
developed based on the cognitive avoidance model (Borkovec & Costello, 1993), the 
metacognitive model of worry (Wells 2005), and the intolerance of uncertainty model 
(Dugas, Gagnon, Ladoceur, & Freeston, 1998). However, testing of such protocols with 







The Dugas and Roubichaud (2007) Treatment Approach 
The Dugas and Roubichaud (2007) treatment approach is based on a cognitive 
model of GAD proposed by Dugas et al. (1998). The model has four main features: 
intolerance of uncertainty, positive beliefs about worry, poor problem orientation, and 
cognitive avoidance (Dugas et al., 1998). Dugas et al. (1998) describe intolerance of 
uncertainty (negative beliefs about uncertainty and its consequences) as a higher order 
process, which drives the other three components. The model has been found to have 
considerable diagnostic and symptom specificity (Dugas, Marchand, & Ladouceur, 
2005).   
The accompanying GAD treatment protocol (Dugas & Roubichaud, 2007) 
focusses on excessive and uncontrollable worry with the aim of increasing participants’ 
acceptance and tolerance of uncertainty. The protocol has six modules: 1) 
psychoeducation, 2) uncertainty awareness, 3) exposure, 4) problem-solving, 5) 
exposure to imagined worries, and 6) relapse prevention. Results for working age 
adults have been encouraging (Dugas et al., 2003; Dugas et al., 2010; Ladouceur et al., 
2000). For example, whilst one-to-one CBT and applied relaxation were found to be 
comparable post-treatment, CBT via the protocol led to ongoing improvement at 24-
month follow-up (Dugas et al., 2010). In group delivery for younger adults, CBT via 
the protocol led to significant improvements for all outcome measures post-treatment, 
alongside further treatment gains at 2-year follow-up (Dugas et al., 2003). Promising 
findings have also been reported for older adults in a multiple baseline study (n = 8) in 
which individual delivery of the protocol was examined (Ladouceur, Leger, Dugas, & 
Freeston, 2004). No studies have investigated the effectiveness of the Dugas and 







Study Rationale  
This study evaluated group delivery of the Dugas and Roubichaud (2007) 
treatment protocol to older adults with GAD. The Salkovskis (1995) ‘hourglass model’ 
demonstrates how during stage 1, early uncontrolled evaluations of new therapies (or 
early attempts at adaptation in new populations) are essential foundations of future 
evidence-based practice.  The aim of conducting randomised controlled trials and 
component analyses at stage 2 is to consolidate extant findings and to define causal and 
moderating factors.  The final stage entails testing the therapy in real world settings 
using large-scale service evaluation and clinical audit.  The present study of the group 
delivery of the Dugas and Roubichaud treatment protocol in an older adult sample was 
therefore an example of appropriate work at stage 1 of the ‘hourglass model’ 
(Salkovskis, 1995).  
Primary Aim 
 The overall aim of this study was to evaluate the clinical effectiveness of the 
Dugas and Roubichaud (2007) treatment protocol for older adults with GAD attending 
group CBT.  
Secondary Aims   
1. To pilot the Overcoming Worry Group (OWG) with older adults with GAD. 
2. To assess the feasibility of OWG. 
3. To assess the acceptability of OWG.  
4. To assess the durability of the effect of OWG. 
5. To explore potential mechanisms of change of OWG. 








Primary Hypotheses  
i. Completion of OWG will result in a significant reduction in symptoms of GAD at 
the end of treatment (EOT). 
ii. OWG-completers will maintain treatment gains over the 8-week follow-up (FU) 
period. 
Secondary Hypotheses  
i. Completion of OWG will result in a significant reduction in symptoms 
of depression at EOT. 




The study received NHS ethical approval on the 17 April, 2015 (ref: 
15/YH/0137; Appendix E) and permission to start research within Sheffield Health and 
Social Care NHS Foundation Trust on the 24 April, 2015 (ref: ZQ13; Appendix F). 
Ethical permission to proceed with the project was granted by Sheffield University 
research ethics committee on the 11 May, 2015 (ref: 177057; Appendix G). 
Design 
Case series are uncontrolled observational studies, suited to small N studies, in 
which a number of individual patients receive the same treatment procedure (Barlow, 
Nock, & Hersen, 2008). Case series are therefore an appropriate methodology for the 
early evaluation of a novel intervention (Salkovski, 1995). As illustrated in Figure 1, a 
case series design permitted group and individual level analyses, whilst qualitative 
methods enabled detailed examination of responders and non-responders (Heyvaert, 





An A-B design with follow-up was used in which baseline (BL) scores acted as 
a comparison from which to assess effects of intervention FU (Arntz, Sofi, & van 
Breukelen, 2013; Kratochwill & Levin, 1992; Kratochwill et al., 2013).  As displayed 
in Figure 1, there were three study phases: BL, treatment, and FU. For those 
participants with a stable BL, it was possible to suggest that change occurred as a result 
of intervention, and not time (Arntz et al., 2013).  The FU phase assessed the durability 
of intervention effects.  
Mixed methods are recommended in the early evaluative stages of novel 
complex interventions (Campbell, 2000). Mixed methods enabled the triangulation of 
findings (convergence and complementarity) in order to increase the validity, 
reliability, and credibility of the present study (Erzeberger & Prein, 1997). The 
approach to mixed methods selected was based on a critical realist philosophy, which 
underpins CBT, and which has been shown to be compatible with small N research 

















             
                Figure 1. Graphic illustration of the mixed model case series  











Potential participants were referred from the Sheffield Health and Social Care 
older adult community mental health teams (CMHT) and Sheffield Improving Access 
to Psychological Therapies (IAPT) services. The intervention was advertised through 
emails, team meetings, and presentations at relevant forums and service events. A 
pragmatic recruitment design was adopted and therefore patients were representative of 
routine practice. Recruitment started on the 12 May 2015, and continued until 
screening for the second treatment group started on 11 September 2015.  
Screening sessions were conducted by OWG course facilitators, and during 
these sessions potential participants were given an information sheet about the research 
study and an expression of interest slip (see Appendices H and I). On receipt of an 
expression of interest slip, the chief researcher arranged a face-to-face meeting to 
discuss the research project and take formal consent if appropriate (see Appendix J for 
consent form). At screening, the following inclusion and exclusion criteria were 
applied:  
Inclusion Criteria 
 Aged over 65 years, and already in contact with mental health services.  
 GAD as the primary complaint verified by a mental health clinician using the 
Anxiety Disorders Interview Schedule (ADIS-IV; Brown & Barlow, 2014), and 
to have scored >8 on the generalised anxiety disorder scale (GAD-7; Spitzer, 
Kroenke, William, & Löwe, 2006).  
 Willing, and able, to attend the 12-week group CBT intervention. 
 Able to read, write, and understand English. 
Exclusion Criteria  
 GAD was not the primary reason for referral or diagnosis. 





 Significant cognitive impairment preventing engagement and retention of 
information from the OWG over the course of the intervention and/or a 
diagnosis of dementia. 
 Weighted risk (i.e. presence of active suicidal ideation and associated planning). 
 Diagnosis of personality disorder. 
 Experiencing symptoms of psychosis. 
 Physically unable to attend the group. 
 Evidence of current substance abuse.  
Recruitment 
Figure 2 describes the flow of participants through the study. Referrals for 37 
potentially eligible participants were received (28 from IAPT and 9 from CMHTs). Of 
the individuals that attended screening, 23 met eligibility criteria (96%). Following 
screening, three eligible individuals (13%) opted out prior to the start of treatment (see 
Figure 2 for reasons). Of those who started treatment, 13 individuals (65%) gave 
consent for the research, and seven individuals (35%) chose not to participate in the 
research study, but attended the intervention. Out of 13 research participants, two 
(15%) dropped out of treatment prematurely (dropout group, n = 2), and 11 (85%) 
finished the course of treatment (completer group, n = 11). Reasons cited for dropout 
were poor physical health (n = 1) and family problems (n = 1). At FU, one research 
participant could not be contacted. 
Table 1 presents demographic and clinical information for the research 
participants (n = 13). There were eight female participants (62%) and five males (38%). 
The age range of participants was 69-92 years (M = 73.15, SD = 6.15). All participants 
were White British. Eight of the sample were married (62%), and participants had left 
education at an average age of 15.08 years (SD = 1.66). Eight of the sample were 





psychiatric comorbidity (including diagnosed depression n = 3, 23%). All participants 
met the diagnostic criteria for GAD using the anxiety disorders interview schedule 
(ADIS-IV; Brown & Barlow, 2014). GAD severity ranged between 3.1 and 6.9 (out of 
8), and averaged 4.89 (SD = 1.32). At screening, the average score on the GAD-7 was 




Figure 2. Diagram showing flow of participants. Note. IAPT = Improving Access to 
Psychological Therapies; CMHT = community mental health teams; DNA = did not attend; 



















 The delivery of OWG was facilitated by two senior clinical psychologists, 
working in an older adult CMHT. The psychologists had between 8 and 17 years of 
experience in older adult psychology services. One of the facilitators was an accredited 
CBT therapist, and other had significant CBT experience (6 years). The facilitators 
received monthly supervision from an accredited CBT consultant clinical psychologist 
to discuss the group and treatment integrity.    
Primary Outcome Measure 
The Penn State Worry Questionnaire (PSWQ: Meyer, Miller, Metzger, & 
Borkovec, 1990). PSWQ (Appendix K) measures trait worry and each item is rated 
from 1 (not very typical of me) to 5 (very typical of me). Eleven items are worded in 
the direction of pathological worry, and five items are reverse-worded. Total scores 
were obtained by summing the scores for the positively-worded items (2, 4-7, 9 and 
12–16) with the reverse scores from negatively worded items (1, 3, 8, 10 and 11). 
Higher total scores are indicative of higher levels of excessive and difficult to control 
worrying, and for older adults a cut off score of >50 indicates GAD (Stanley et al., 
2003). PSWQ has shown high internal consistency (= .94), adequate test-retest 
reliability (r = .74), and adequate convergent and discriminant validity in older adults 
(Stanley, Novy, Bourland, Beck, & Averill, 2001; Wuthrich, Johnco, & Knight, 2014).  
Secondary Outcome Measures 
Generalised anxiety disorder scale (GAD-7: Spitzer, Kroenke, Williams, & 
Löwe, 2006). GAD-7 (Appendix L) is a 7-item scale that aims to assess GAD 
symptoms, anxiety-related items (over the last two weeks) are rated from 0 (not at all) 
to 3 (nearly all the time); a score of >5 is said to indicate GAD in older adults (Wild et 
al., 2014). In an older adult sample the GAD-7 has been shown to have good 





al., 2006; Vasiliadis, Chudzinski, Gontijo-Guerra, Préville, 2015; Wild et al., 2012). 
Intercorrelation with the PHQ-9 was moderate, r = .64 (Löwe et al., 2008).   
Patient Health Questionnaire (PHQ-9: Spitzer, Kroenke, & Williams, 
1999). PHQ-9 (Appendix M) is a 9-item scale that is used to assess for major 
depressive disorder; depression symptom items (over the last two weeks) are rated from 
0 (not at all) to 3 (nearly all the time) (Löwe, Kroenke, Herzog, & Grafe, 2004). A total 
score of >10 is considered to predict a diagnosis of depression, and increasing scores 
are considered indicative of greater symptom severity (APA, 1994; Phelan, 2010). With 
older adults, the PHQ-9 has been shown to have adequate internal consistency (= 
.78), good test-retest reliability (r = .81), and adequate convergent and discriminant 
validity (Dear et al., 2013; Löwe et al., 2004; Phelan et al., 2010).  
Daily diary. The daily self-monitoring diary (Appendix N) included a key 
target variable in relation to the treatment of GAD drawn from the GAD-7, ‘I have 
been worrying too much about different things’ (Spitzer et al., 2006). The diary also 
included a second variable which asked participants’ to rate the extent to which they 
considered themselves to be trying out the things they had learned in the group.  
Process Measures   
The Intolerance of Uncertainty Scale (IUS; Freeston et al., 1994). IUS 
(Appendix O) aims to establish the reactions that individuals have to ambiguous 
situations, implications of uncertainty, and their efforts to control future events. There 
are 27 items in total, and all items are rated on a 5-point scale, 1 (not at all 
characteristic of me) to 5 (entirely characteristic of me). Items are added up, and higher 
scores indicate higher levels of intolerance of uncertainty beliefs. IUS is frequently 
used as a measure of process when evaluating the Dugas and Roubichaud (2007) 
treatment approach (Gosselin, Ladouceur, Morin, Dugas, & Baillargeon, 2006). 





English version of IUS has been shown to have high internal consistency 
((Buhr & Dugas, 2002)Additionally, IUS has been shown to have moderate 
concurrent validity with the PSWQ (r = .60), adequate test-retest reliability over a five-
week period (r = .74), and adequate convergent and divergent validity when assessed 
with symptom measures of anxiety, worry, and depression  (Buhr & Dugas, 2002).  
Elliott’s Client Change Interview (Elliott, Slatick, & Urman, 2001). The 
change interview is a 30–90 min semi-structured interview used to provide a qualitative 
overview of factors clients find helpful in treatment (Appendix P; Elliott et al., 2001). 
Clients are asked to consider changes/stasis/deterioration, and associated expectations, 
significance, and attributions. The change interview has been used in a number of 
qualitative examinations of the helpful factors of therapy (Israel, Gorcheva, Burnes, & 
Walther, 2008; Levitt, Butler, & Hill, 2006; Mörtl & Von Wietersheim, 2008), and in 
mixed methods single-case research (Kellett & Hardy, 2013). 
Measure of Treatment Integrity 
Session-by-session treatment integrity was rated using a 14-item (6-point) 
fidelity coding guide developed specifically for assessing the integrity of group CBT 
(See Appendix Q; Hepner et al., 2011). Treatment integrity is rated from 0 to 84 
(higher scores reflect sessions considered to have higher fidelity to the CBT). A 
qualified CBT therapist independently rated 8% of sessions (2/24 sessions).  
Procedure 
There were 16 main data collection points over three study phases (BL, 
intervention, and FU; see Table 2). Following referral, potential participants attended a 
screening appointment at which they were screened against inclusion/exclusion criteria. 
Eligible participants were provided with an information sheet and a letter of invitation 





and I). Individuals were informed that their decision not to participate in the research 
would not affect treatment offered.  
On receipt of a completed ‘expression of interest’ form, a face-to-face meeting 
was arranged between the chief researcher and the potential research participant. This 
was an opportunity for potential research participants to have any further questions 
about the research answered. At this point participants choosing to take part in the 
research were invited to complete a written consent form (Appendix J). Participants 
were informed of their right to withdraw at any point, and confidentiality and 
anonymity of data was assured. Consenting participants then filled out a full battery of 
outcome measures. Immediately prior to the start of the intervention, participants 
completed the GAD-7 and were given the daily worry diary.  
Over the intervention phase, participants completed the GAD-7 prior to each 
intervention session, and the daily diary between sessions. Unless otherwise indicated 
(e.g. poor health), dropouts were invited to complete a dropout feedback form which 
asked about the acceptability, feasibility, and initial efficacy of the group and the 
research (Appendix R).  At EOT, completers filled out the full battery of outcome 
measures and were invited to provide further consent to take part in a taped change 
interview (see Appendix S for consent form for EOT interview, see Appendix P for 
change interview schedule). Lastly, at 8-week FU participants completed all outcome 
measures.  
Facilitating psychologists attended focus groups after both treatment groups to 
discuss their experiences of delivering the intervention, and the research. The focus 
group schedule (Appendix T) was designed and administered based on guidance by 
Krueger (2002). Each focus group lasted 30–60 mins and was guided and chaired by 









The Intervention  
The OWG treatment manual (Appendix U for an example) and accompanying 
materials were developed by the research team, based on group delivery of the Dugas 
and Robichaud (2007) GAD treatment manual for older adults. Adaptations to the 
Dugas and Roubichaud protocol included those described by Ladoceur et al. (2004) in 
their individual delivery of the protocol to older adults. For example, OWG included 
planned times for participants to share their knowledge and experiences of living and 
coping with anxiety and worry (e.g. group discussion exercises). OWG also reflected 
recommendations for adapting CBT for group delivery with older adults (such as 
slower pacing, multimodal learning, and memory aids; Bains, Scott, Kellett, & Saxon, 
2014). To increase multi-modal learning, the OWG manual included presentations, 
group discussions, games, written tasks, and homework (such as behavioural 
experiments). An initial draft OWG was tested through a pre-pilot in September 2014 
(n = 5). Changes made on the basis of feedback (participant and facilitator) included 
additional handouts (such as a handout with an example of a hypothetical worry draft), 
and more detailed facilitator ‘tips for delivery’ in the session guides.  
The OWG was delivered over 12 weekly sessions, each lasting 2 hours. There 
were a maximum of 12 participants in each group. The OWG included three phases: 





prevention (sessions 11 and 12). Awareness training included ‘understanding worry’ 
and ‘noticing the difference between real and hypothetical worries’. There were four 
worry interventions: a) experiments to increase tolerance of uncertainty, b) evaluation 
of worry beliefs exercises, c) tasks to increase problem-solving skills, and d) a 
cognitive exposure to hypothetical worry exercise.  The OWG ended with relapse 
prevention sessions in which content was recapped and participants developed bespoke 
relapse prevention plans (Hjemdal, Hagen, Nordahl, & Wells, 2013). All sessions had a 
consistent structure, starting with homework review and a recap on the previous week, 
and ending with homework setting. Throughout treatment, participants were asked to 
keep a daily diary to monitor their worry levels (see measures section).  
Data Analysis  
Mixed data was predominantly analysed in parallel using separate quantitative 
and qualitative analysis methods, as is often the case for triangulation studies in which 
convergence is being assessed (Tashakkori & Teddlie, 1998). However, for 
complementarity purposes, sequential mixed model analyses were also used to explore 
factors that may explain initial differences (quantitative or qualitative) in efficacy and 
change outcomes. ‘QUAN’ analyses were used to form subgroups of patients 
(recovered vs. not recovered patients), and the differences between these subgroups of 
participants were then analysed further using ‘qual’ methods. In addition, ‘QUAL’ 
analyses were used to form subgroups of patients (based on reported changes), and the 
differences between subgroups were then analysed further using ‘quan’ methods. 
            Quantitative analyses. Descriptive statistics were used to describe dropouts 
and completers in terms of demographic and clinical factors. Chi-squared tests explored 
any between-group differences (completers vs. dropouts) in baseline characteristics. 
Attendance, homework completion rates and treatment integrity ratings were calculated 





Individual level analyses. Individual participant outcomes were presented 
graphically to illustrate progress over time, and to display any trends occurring across 
study phases. BL data was visually examined for stability. Evidence of reliable 
improvement reliable improvement, and clinically significant improvement (CSI), is 
increasingly utilised to categorise ‘recovery’ in practice-based evidence, and was the 
criteria for recovery adopted in this study (Wise, 2004). The primary outcome measure 
used was the PSWQ, and the main outcome point was EOT. The Reliable Change 
Index (RCI) was calculated using the Jacobson methodology, thus change exceeding 
1.96 times the standard error of the difference of the PSWQ was considered statistically 
reliable (Jacobson & Truax, 1991). For the PSWQ, this meant that an improvement in 
scores of >17 was classified as reliable improvement, calculated on the basis of a data 
from large older adult clinical sample (Wuthrich et al., 2014). CSI was recorded for 
participants who had moved from the clinical range to the normal range. The clinical 
cut-off for GAD in older adults, as measured by the PSWQ is >50, and thus CSI was 
considered if participants moved from >50 (pre) to <50 (post) (Stanley et al., 2003). 
The number and percentage of participants deteriorating reliably (i.e. showing 
deterioration in score of >17), and/or showing clinically significant deterioration 
(moving from the normal range to the clinical range), on the PSWQ was also reported.  
Reliable and clinical change calculations were then repeated for the secondary 
measures using older adult data where available. For the GAD-7, the RCI was a change 
score of >5 and the clinical cut-off was 5 (Wild et al., 2014). The RCI for the PHQ-9 
was a change score of >6 and the clinical cut-off was 10 (Löwe et al., 2004).  For the 
IUS there was no clinical cut-off, or older adult data available, but a RCI of >14 was 
adopted as per previous studies of working aged adults (Boswell, Thompson-Hollands, 





Daily self-monitoring diaries were analysed using percentage of non-
overlapping data methodology, an accepted indicator of treatment effectiveness (Parker 
& Vannest, 2009). Three methods of calculating non-overlapping data were used in 
recognition of the limitations of each: the Percentage of Non Overlapping Data (PND; 
Scruggs, Mastropieri, & Casto, 1987), the Percentage of All Non Overlapping Data 
(PAND; Parker, Hagan-Burke, & Vannest, 2007), and the Percentage Exceeding the 
Median (PEM; Ma, 2006). Non-overlapping data results can be classified in relation to 
treatment effectiveness as: 50-70% = questionable effectiveness, 70-90% = moderate 
effectiveness, and over 90% = high effectiveness (Wendt, 2009). 
Group level analyses. Effect size calculations were used to provide a 
comparative mean change in the primary outcome measure (Fritz, Morris, & Richler, 
2012). Effect size calculations (with 95% confidence intervals) were calculated as 
follows:  (mean PSWQ score at BL – mean PSWQ score at EOT)/standard deviation of 
PSWQ scores at BL. Standard error of the mean pre-post change provided 95% 
confidence intervals. This was then repeated for secondary outcome measures (GAD-7, 
IUS, and PHQ-9). Effect sizes were considered according to Cohen’s (1992) power 
primer: d > 0.20 = small effect, d > 0.50 = medium’ effect, and  d > 0.80  = large effect. 
In order to provide a conservative estimate of the clinical effectiveness of OWG, 
intention-to-treat analyses (ITT) were conducted, employing the ‘last observation 
carried forward method’ in relation to the effect size calculations (Hollis & Campbell, 
1999). Alongside this, effect sizes obtained were benchmarked against similar group 
CBT studies for older adults with GAD. The significance of changes in GAD 
symptoms (GAD-7 and PSWQ), tolerance of uncertainty (IUS), and depression 
symptoms (PHQ-9) over the course of the OWG was considered using the Wilcoxon 






            Qualitative analyses. Digitally recorded completer interviews (n = 11) and 
facilitator focus groups (n = 2) were transcribed verbatim by the chief researcher. Two 
methods of data-driven thematic analysis (TA) described by Boyatzis (1998) were used 
(inductive and hybrid; Table 3). Data-driven approaches are reported to result in themes 
with higher interrater reliability and increased validity against relevant criteria 
(Boyatzis, 1998). 
Inductive TA. Nine-step criterion-driven inductive TA (Table 3; Boyatzis, 1998) 
was used to analyse participant change interview data (questions 3-7). The criterion 
variable of ‘recovered vs. not recovered’ was selected based on the study aims. To 
enhance reliability, a second researcher (a trainee also using TA at a doctorate level) 
applied the coding frame to 30% of the raw data (Boyatzis, 1998). Overall agreement 
for themes was calculated using Cohen’s kappa, and codes for which there were lower 
levels of agreement were further clarified, or dropped, to increase validity (Boyatzis, 
1998).  
Hybrid TA. Hybrid TA was used to analyse change interview data (questions 1 
and 8), and facilitator focus group data, given that there was no evident criterion 
variable for this data (Boyatzis, 1998). Hybrid TA involved a 5-step process in which 
steps 2, 5, 6, and 9 were omitted (Table 3; Boyatzis, 1998). Therefore, in contrast to 
inductive TA, the development of meaningful themes was theory and research–driven 
(Boyatzis, 1998). The small data sets analysed using hybrid TA did not permit 








            Data triangulation. In order to increase the transparency and replicability of 
data triangulation, an adapted version of a protocol used for triangulating mixed 
method qualitative data was developed (Table 4; Farmer, Robinson, Elliott, & Eyles 
2006; Henwood et al., 2015). To increase the reliability of convergence codes assigned, 





convergence codes for which there were discrepancies were discussed until agreement 





Participants were informed that research participation was voluntary, and that 
they could attend the group without taking part in the study. Participants were informed 
of their right to withdraw from the study at any point, without giving a reason, and that 
this would not affect their healthcare. An adverse incident procedure was in place to 
ensure participant safeguarding.  The study was monitored by the university and the 
host trust’s governance department. All data was stored securely and anonymously.   
Results 
Results are organised into the following sections: (a) quantitative (uptake and 
attendance, individual level analyses, group level analyses, and benchmarking), (b) 
qualitative (participant and facilitator experience), (c) QUAN-qual, (d) QUAL-qual, 






Uptake and attendance. Table 5 contains BL descriptives for completers (n 
=11) and dropouts (n = 2). Dropouts were significantly more anxious (GAD-7) at BL 
than completers (U = 1.0, z = -2.0, p = .048). No other BL characteristics differed 
significantly between completers and dropouts. Average weekly attendance and 
homework completion rates were 87% (range 64-100%), and 73% (range 43-100%), 
respectively. Treatment integrity ratings averaged 94% (range 93-94%). 
Individual outcomes. Figures 3-8 display individual OWG outcomes, with 
interpretation of trends summarised in Table 6. In short, BL stability was apparent for 
5/11 participants (45%), positive treatment effects for 7/11 participants (64%), and 
further gains over FU were observed for 3/10 participants (30%). Analysis of daily 
diary scores for the four participants that provided data during BL and treatment phases 
(Table 7), classified treatment as either ‘ineffective’ (participants 1 and 4) or of 
‘questionable effectiveness’ (participants 6 and 8).  
The reliability and clinical significance of individual change scores are 
displayed in Table 8, and are summarised in Table 9. At EOT 5/11 participants met the 
PSWQ recovery criteria (46%), increasing to 7/10 at FU (70%). No participant showed 
reliable or clinical deterioration on the PSWQ, including over FU. 
Of those who were above the clinical threshold on the PHQ-9 at BL, 2/4 participants no 
longer met the criteria for depression at EOT (50%), which reduced to 1/3 at FU (33%).  
From BL to EOT one participant showed reliable deterioration on the IUS (9%), 
no other participants showed reliable deterioration on any outcome measure. Over FU, 
reliable and clinically significant deterioration was shown on the GAD-7 by two 
participants (20%). One of these participants also showed clinically significant 
deterioration on the PHQ-9 from BL to FU (10%), and was the only participant that 








































































      












































                                                                                                                            
           







Group level outcomes. Figure 9 shows mean weekly GAD-7 outcomes and 
shows anxiety levels improved over BL, and continued to improve steadily over the 
course of treatment. Figure 10 displays mean outcomes for GAD-7 and PHQ-9, which 
show improvements in anxiety (GAD-7) and depression (PHQ-9) from BL to EOT, and 
relative stability over FU. Figure 11 displays mean PSWQ and IUS outcome scores, 
showing levels of worry (PSWQ) and intolerance of uncertainty (IUS) improved from 
BL to EOT. Over FU, worry levels showed slight improvement, whilst tolerance of 
uncertainty levels showed marginal deterioration. 
Table 11 reports the statistical significance of change scores. Mean change in 
GAD-7 scores over BL were significant (z = -2.67, p = .08), unlike PHQ-9 scores  
(z = -1.19, p = .23); indicating BL stability for depression (PHQ-9) symptoms, but not 
for anxiety (GAD-7) symptoms. Change scores on all outcome measures indicated 
significant improvement from BL to EOT, and non-significant change from EOT to 
FU. Additional analyses found weekly GAD-7 scores did not change significantly 
between any two consecutive treatment sessions (see Figure 9 for a graphical display of 
weekly GAD-7 outcomes). 
Completer and ITT effect sizes are displayed in Table 12. Completer worry 
(PSWQ) effect sizes were large at EOT, d = 2.59 (CI95: -0.99, 4.12) and FU, d = 2.82 
(CI95: 1.16, 4.50). ITT worry (PSWQ) treatment effect sizes remained large at EOT, d = 
2.04 (CI95:  0.70, 3.38), and FU, d = 2.02 (CI95: 0.69, 3.36). Completer depression 
(PHQ-9) treatment effect sizes were small-to-medium at EOT, d = 0.49 (CI95: -0.71, 
1.69), and medium at FU, d = 0.55 (CI95: 0.66, 1.75). IUS effect sizes for completers 





                                               
Figure 9. Mean GAD-7 outcomes over study and treatment phases. Note. BL = baseline; FU = 








Figure 10. Mean GAD-7 and PHQ-9 outcomes across the study. Note. BL = Baseline;  
EOT = end of treatment; FU = follow-up.  
 
 
Figure 11. Mean PSWQ and IUS outcomes across the study. Note. BL = Baseline;  



















  Benchmarking. Table 12 presents benchmarked findings and shows that the 
OWG had an equivalent opt-in rate, lower dropout rate, and a larger EOT PSWQ effect 




Qualitative Analyses: The Participant Experience  
Using hybrid TA, five participant themes emerged, regarding acceptability and 
feasibility of the OWG: 
 Theme 1: Enjoyable. Many of the participants (10/11) described the OWG as 
an enjoyable and social experience. 
 
I’ve enjoyed it, I think some of the time it was just meeting people as well (Participant 
8). 
 
Theme 2: Better in a group than expected. Almost half of the participants 
(5/11) described coping better with group-based treatment than expected.   
 







 Theme 3: Supportive facilitators. Facilitators were described as supportive 
and patient by the vast majority of participants (9/11). 
 
If you didn’t understand you just had to say and they went over it again (Participant 
11). 
Theme 4: Not as expected. Almost half the participants indicated (5/11) that 
they had expected something different from the intervention. 
 
A few of us went to find out why we behave like this, but obviously the group didn’t 
cover that (Participant 1). 
 
 Theme 5: Why invent worries! The hypothetical worry exposure task was not 
liked by many of the participants (5/11). 
 
We had one week it was, I forget what it was titled and you think about going into a 
care home. One week it was a bit oh, made you go a bit like that. I thought I don’t know 
whether I like that (Participant 7). 
 
Qualitative Analyses: The Facilitator Experience 
Eight themes emerged from hybrid TA of the facilitator focus group transcripts. 
Theme 1: OK together. Group delivery with other older adults was described 
by facilitators as an acceptable and ‘normalising’ treatment format. 
 
People were very clear they liked being in a group with older people. It was something 





Theme 2: Drop the diary. Facilitators described the daily diary as 
unacceptable for many of the participants: 
 
I don’t think the worry diary works generally. I think most people don’t like it, there’s 
one or two that will do it, but most people don’t like it (Psychologist 2, OWG2). 
 
 Theme 3: Too much paperwork for some. Facilitators suggested that they felt 
there were too many handouts for some of the participants. 
 
One person felt and a few people agreed it’s too many handouts (Psychologist 1, 
OWG1). 
 
 Theme 4: Familiar co-facilitator helped. Previous experience of co-delivery 
was described as a factor which increased the feasibility of delivery.  
 
I think it worked well because you and I have worked together a lot. So it made 
facilitation easy (Psychologist 2, OWG1). 
 
 Theme 5: Structure helps. Facilitators described the regular structure of the 
weekly protocol as a positive/helpful aspect of delivery. 
 
I like the overall format. The familiarity, we start off the same and it pretty much ends 
the same. I think people respond quite well to that (Psychologist 1, OWG1). 
 
 Theme 6: Invisible research. The research study was not something facilitators 





I think it was quite good that I forgot who was in the research, everyone just did the 
same things every week (Psychologist 2, OWG2). 
 
Theme 7: Doing helped. Facilitators described the behavioural experiments as 
a helpful element of treatment.  
 
I think the behavioural experiments are really key. Really good at keeping that 
consistency of doing things differently (Psychologist 1, OWG2). 
 
 Theme 8: Positive feedback. Facilitators shared positive feedback from 
participants, and their networks.  
 
He’d [participant’s husband] got his wife back and he was very positive about the 




Table 13 illustrates that four themes maximally differentiated the experience of 
participants who met the criteria for recovery at the end of the OWG (n = 5) from those 
that did not (n = 6). Following second rating of 30% of the transcripts one potential 
theme was dropped due a low level of agreement between raters, and further detail was 
added to the coding template for theme 3a. Following this, good interrater agreement 








Theme 1: Difference vs. identification. Many of the participants who 
recovered reported feeling somewhat different from the rest of the group (3/5; Theme 
1a ‘Feeling different’).  
 
There was only one lady who didn’t come very often so it was four or five men and  
me (Participant 10). 
 
In contrast, participants who did not recover more frequently described similarity with 
the other group members (4/6; Theme 1b ‘identification’). 
 






Theme 2: Opening up vs. holding back. Participants who recovered were 
more likely to mention that they or others had shared their thoughts and feelings during 
OWG (3/5; theme 3a ‘opening up’). 
 
I felt that my confidence grew you know as the weeks went by and I felt more 
comfortable you know at saying how I felt (Participant 6). 
 
Non-recovered participants did not mention sharing their feelings in the group, 
and a few went on to describe the OWG as somewhere they or others had ‘held back’ 
(2/6; theme 3b).  
 
I wanted to bring something up but I decided not to (Participant 8). 
 
 Theme 3: Doing for learning vs. reporting back. For participants who 
recovered, trying new things was often linked to better coping or personal learning 
(3/5; theme 3a ‘personal learning’).  
 
I forget what I was worrying about but I said to myself this is a hyp-o-thetical worry 
and it stopped. They do still come back but I’m controlling it and it is happening less 
(Participant 9) 
 
 In contrast, non-recovered participants frequently described the importance of 
sharing achievements with the group (4/6; theme 3b ‘reporting back’).  
 
I’ve done loads of things, and that’s been good cos each week we’ve gone back and 





Theme 4: Somatic changes. Lastly, for those that recovered, somatic changes 
were often apparent (3/5; theme 4). 
 
It’s less than it were because I don’t have this errr, when the anxiety comes on it’s like 
a quivering in my body (Participant 5). 
 
Only one non-recovered participant mentioned having noticed physiological 
changes since treatment (1/6). 
Qual-QUAN Findings 
Quantitative analysis of change interview data found that participants reported 
an average of 1.91 positive changes at the end of OWG (SD = 0.94). Almost all 
changes observed (95%) were described as either ‘somewhat’ or ‘extremely’ unlikely 
without treatment. Observed changes were most frequently attributed to the following: 
learning about hypothetical worries (19% of changes), trying new things (19%), and 
general course content (19%). Over half of the observed changes (59%) were described 
by participants as ‘very important’. 
Triangulation of Mixed Findings 
Table 14 displays convergence codes assigned to triangulated mixed method 
findings. Acceptability and feasibility findings were coded as ‘confirmatory’. Initial 
efficacy (GAD symptoms) findings were coded as ‘discrepant’ for the likelihood of 
change without treatment, and ‘confirmatory’ for all other effectiveness findings. 
Mixed data convergence coding was not possible for initial effectiveness (depression 
symptoms) or durability findings given mono-method findings. Initial inter-rater 
reliably for convergence codes assigned was excellent, κ= .88 (CI95: 0.64, 1.12), p 
<.001, and complete agreement on all nine codes was reached following discussion 


























This study evaluated delivery of the Dugas and Roubichaud (2007) protocol for 
older adults with GAD in a group setting. An adapted protocol, the OWG, was pre-
piloted to test for initial feasibility and acceptability. Following minor changes, the 
OWG was formally piloted to assess acceptability, feasibility, initial effectiveness, 
durability, and potential change mechanisms. There were four study hypotheses: (i) that 
there would be significant reductions in GAD symptoms following treatment, (ii) that 
treatment gains for GAD symptoms would be maintained over 8-week FU, (iii) that 
there would be improvements in depression symptoms post-treatment, and (iv) that 
depression treatment gains would show durability over FU.  
Summary of Findings 
 Acceptability. OWG was an acceptable treatment. The opt-in rate (87%) was 
comparable to rates reported in trials of individual CBT for older adults with GAD 
(91%: Stanley et al., 2009; 93%: Stanley et al., 2014). In addition, the dropout rate 
(15%) was lower than previous studies of group CBT for older adults with GAD (26-
39%: Stanley et al., 1996; Stanley et al., 2003; Wetherell et al., 2003). Feedback from 
participants and facilitators was confirmatory. Participants reported that they had 
enjoyed treatment and that being in a group had been better than expected. Facilitators 
commented that participants had appeared to benefit from being with one another for 
treatment. The two participants that dropped out cited health and family problems as 
their reasons for dropout, as opposed to factors pertaining to the acceptability of the 
group. 
Rates of dropout (15%), attendance (87%), and homework completion (73%) 
suggested course content was generally acceptable. Qualitative findings were 
expansive, and indicated that the volume of paperwork, the daily diary, and the 





participants. Written tasks appeared to have been poorly received, which may have 
reflected cohort experiences of formal education (for example, as punitive) (Laidlaw, 
Thompson, & Gallagher-Thompson, 2004).  
Feasibility. Treatment integrity ratings suggested that per protocol delivery was 
feasible. Facilitator feedback was confirmatory and also suggested that feasibility had 
been enhanced in two ways: delivery with a familiar co-facilitator and the structure of 
the protocol. Facilitators also reported that the research methodology had been feasible 
and unobtrusive, and that they felt unaware of which patients were in the research. This 
would appear to have reduced the risk of performance bias; differential treatment of 
patients on the basis of research participation status (Higgins & Green, 2011). 
Participants indicated that the approach of the facilitators (such as patience and 
openness to recapping) had increased the accessibility of the treatment protocol. Both 
psychologists had considerable experience in older adult services (8-17 years).  A 
recent study by Stanley et al. (2014) found equivalent outcomes of CBT for older adults 
with GAD when delivered by paraprofessionals and experienced therapists. However, 
present findings appear to support the suggestion that geropsychology competence can 
increase the feasibility of CBT delivery with older adults (Karel, Gatz, & Smyer, 2012). 
 Initial efficacy (symptoms of GAD). As hypothesised (i), large completer and 
ITT effect sizes for symptoms of GAD were found post-treatment. PSWQ effect sizes 
herein exceeded effect sizes reported in previous trials of group CBT for older adults (d 
= 0.53-90: Stanley et al., 1996; Stanley et al., 2003; Wetherell et al., 2003), and 
immediately following treatment, 45% of participants met the recovery criteria for 
symptoms of worry. Facilitator feedback findings were complementary, and positive 
feedback from participants, family members, and multidisciplinary colleagues was 
reported. Encouragingly, no participants showed clinical and/or reliable deterioration 





Participant interview findings indicated that recovered participants were more likely to 
have noticed reduced somatic symptoms than those who did not recover. Donegan and 
Dugas (2012) found that following treatment with the Dugas and Roubichaud (2007) 
protocol, change in worry accounted for significant change in somatic symptoms, and 
vice-versa.   
However, BL stability (GAD-7 scores) was not demonstrated for 6 out of 11 
participants, thus for these individuals it was not possible to assert that change was a 
result of the intervention, and not time (Arntz et al., 2013). This was discrepant with 
participant change interview findings which found that for almost all participants 
change was described as being somewhat to extremely unlikely without the OWG.  
Durability (symptoms of GAD).  None of the participants showed significant 
deterioration in worry symptoms (PSWQ) over FU. This finding suggested durability 
of worry treatment gains, and provided support for study hypothesis (ii). Furthermore, 
GAD recovery rates increased over FU.  Comparable remission rates (60-77%) have 
been reported for the delivery of the worry protocol to working aged adults, suggesting 
equivalence of treatment effects irrespective of age (Dugas & Roubichaud, 2007).  
Comorbidity. In support of study hypothesis (iii), following treatment there 
was a significant overall improvement in participants’ depression symptoms (PHQ-9). 
CBT targeting late-life GAD has commonly found to reduce symptoms of depression 
(Gorenstein et al., 2005; Stanley et al., 2003; Wetherell et al., 2003). Promisingly, the 
small-medium depression effect size observed herein was equivalent to that reported in 
a comparable practice-based trial of group CBT targeting mixed anxiety and depression 
(d = 0.40; Bains et al., 2014).  
Mean change in depression symptoms (PHQ-9) was found was to have been 
non-significant over FU which suggested depression treatment gains were maintained 





recovered) participant showed clinically significant deterioration in depression (PHQ-
9) and anxiety (GAD-7) symptoms during FU. Exploring reasons for positive and 
negative changes over FU (e.g. using the change interview at FU), could provide 
valuable insight into the durability of the protocol and guidance on relapse prevention.  
 Potential change mechanisms (GAD symptoms). IUS scores indicated 
significant positive change in participants’ ability to tolerate uncertainty following 
treatment, and this converged with facilitator feedback that behavioural experiments 
were a helpful aspect of treatment. Convergence of mixed method findings, therefore 
suggested enhanced tolerance of uncertainty contributed to positive treatment gains. 
This finding is consistent with research that has demonstrated that improved tolerance 
of uncertainty mediated positive change in pathological worry following CBT for GAD 
in younger adults (Bomyea et al., 2015). Participant interview findings were expansive. 
For example, participants who recovered often linked trying new things to learning or 
development. In contrast, non-recovered participants more frequently linked trying new 
things to the importance of sharing achievements with the group. For some non-
recovered participants, additional support to notice and assimilate learning from 
between-session tasks may have been beneficial (Glenn et al., 2013; Rees, McEvoy, & 
Nathan, 2005).  
Clinical Implications 
Large ITT treatment effects for symptoms of GAD were observed. This 
contrasts extant literature which has reported modest treatment effects for GAD in 
older adults (Gonçalves & Byrne, 2012). Group delivery of the Dugas and Roubichaud 
(2007) protocol therefore appears a promising approach for older adults with GAD. 
Given that older adults with GAD are found to prefer psychotherapy over medication, 
this is an important finding in relation to patient choice (Mohlman, 2012). Group 





psychological interventions for older adults with GAD (McCrone et al., 2009). 
However, research has found that older adults with anxiety (aged 65-74 years) 
generally select individual over group therapy, therefore work to address 
preconceptions of group therapy is indicated (Mohlman, 2012; Morrison, 2001). 
Findings suggest potential improvements to OWG. Low rates of diary 
completion alongside facilitator feedback indicated that it may be advisable to discard 
the daily diary and streamline handouts. The hypothetical worry exposure exercise was 
also poorly received, which suggests the OWG protocol needs to be amended to better 
prepare participants for this task (i.e. spend more time on the rationale).  Further 
consideration of cohort factors (such as differing experience of education between 
participants and clinicians) may lead to increased protocol acceptability; as suggested 
in the Comprehensive Contextualization Framework (CCF; Laidlaw et al., 2004). 
Lastly, small to medium, durable, treatment effects for depression symptoms 
have been demonstrated. This suggests that the protocol may be an effective treatment 
option for the estimated 28-60% of older adults with a diagnosis of GAD and comorbid 
depression (Parmalee, Katz, & Lawton, 1993; Porensky et al., 2009).  
Theoretical Implications 
Current findings suggest that the key target of the Dugas and Roubichaud 
(2007) protocol, intolerance of uncertainty, may be an important treatment target for 
older adults with GAD.  Reviews have found that CBT for GAD may be less effective 
for older adults than for younger adults (Covin et al., 2008; Hall, 2016). However, this 
study has reported equivalent remission rates to those found for younger adults (Dugas 
et al., 2003). Findings suggest that older adults may not require unique 
psychotherapeutic treatment approaches for GAD (Wolitzy-Taylor et al., 2010). 
However, age-related modifications to existing CBT protocols appear advantageous 





Effect sizes obtained were greater than those found in a case series study (n = 8) 
of the individual delivery of the worry protocol (Ladouceur et al., 2004). Facilitator and 
participant feedback suggested that the non-specific benefits of group therapy, such as 
reduced social isolation and peer support, may have been important (Krishna et al., 
2010; Lewinsohn & Clarke, 1999; Morrison, 2001; Yalom & Leszcz, 2005). 
Methodological Limitations 
There were a number of study limitations that should be considered. Whilst the 
small sample size limits generalisability of findings, the sample size was appropriate to 
study aims. This evaluation has been consistent with stage 1 of the hourglass model for 
the development of new/newly adapted therapies (Salkovskis, 1995).  
A number of the weaknesses of this study reflect the methodological 
compromises of conducting practice-based outcome research (Barkham & Margison, 
2007). For example, BL data was not collected on more than two occasions for any of 
the measures (except the GAD-7). This reduces confidence in the changes observed 
being directly attributable to OWG, as three stable BL observations are required to 
control for the confounding effect of time on treatment outcomes (Tate et al., 2008). As 
participants attended different groups, this also reduces comparability of phases, as 
participants were exposed to different group climates (Lo Coco, Gullo, Lo Verso, & 
Kivlighan, 2013).  However, potential between-group variability was reduced where 
possible (e.g. both groups had the same facilitators, setting and were held at the same 
time of the day). 
Instability of mean baseline data (GAD-7) reduced confidence in conclusions 
with respect to the role of the OWG in change scores observed. However, this finding 
was in contrast with change interview data that suggested that almost all the 
participants considered change was ‘somewhat to extremely unlikely’ without OWG. 





immediately prior to the first group treatment session. Yalom and Leszcz (2005) 
suggested a key factor in group therapy can be ‘universality’, and it may have been that 
for some participants the prospect of seeing other older adults with GAD offered hope, 
which in turn reduced outcome scores (Gum, Synder, & Duncan, 2006; Synder et al., 
1991). Also, durability and initial efficacy (for depression symptoms) findings were 
mono-method, which meant it was not possible to assess mixed method convergence, 
reducing the reliability and validity of these findings. 
Participants were young-old (average age of 73 years), as is common in CBT 
trials for GAD in older adults (Hall, 2016). Laidlaw and Kishita (2015) propose that the 




 decade) may have more complex health 
comorbidities, and intergenerational structures, that need to be accounted for in adapted 
CBT protocols. In line with this, the oldest OWG participant (aged 92 years) dropped 
out due to poor health. Trial findings may therefore not generalise easily to the 
increasing numbers of oldest-old presenting to services (Laidlaw & Kishita, 2015).  
Future Research 
A pilot RCT is indicated in order to assess the efficacy and cost-effectiveness of 
OWG. An active comparison group is recommended, as passive controls can inflate 
treatment effects (Mohr et al., 2009). As FU was relatively short, future trials are 
encouraged to include a longer FU period to examine durability of treatment effects 
more comprehensively. Researchers should consider pluralistic measures to strengthen 
the validity and reliability of psychotherapy outcome assessments such as proxy ratings 
(clinician and/or significant others), or magnetic resonance imaging scanning which has 
been used to detect successful pharmacological treatment of GAD in older adults 
(Andreesccu et al., 2015; Brown & Barlow, 2014; Ketter, 2010; Steel, Geller, & Carr, 
2005). Evidence has suggested intolerance of uncertainty may play a role in the 





depression; Boswell et al., 2013). Application of the Dugas and Roubichaud (2007) 
protocol, which targets intolerance of uncertainty, led to significant reductions in levels 
of intolerance of uncertainty, worry, and depression. Future studies should examine the 
potential role of intolerance of uncertainty as a mediator of transdiagnostic treatment 
gains following delivery of the Dugas and Roubichaud protocol (Bomyea et al., 2015).   
 
Conclusions 
This study suggests group delivery of the Dugas and Roubichaud (2007) worry 
protocol is an acceptable and feasible treatment option for older adults with GAD. In 
comparison to previous trials of group CBT for older adults with GAD, large treatment 
effects at the end of treatment and at follow-up were found. Change mechanism 
findings suggest that addressing intolerance of uncertainty may have enabled change in 
chronic worry. The protocol shows real promise as a treatment for GAD in older age 
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Appendix K. Penn State Worry Questionnaire  



































Appendix L. Generalised anxiety disorder scale  



































Appendix M. Patient Health Questionnaire  



































Appendix N. Daily Worry Diary 



































































Appendix P. Change Interview Protocol  



































Appendix P. Change Interview Protocol  





































Appendix P. Change Interview Protocol  
(continued; Elliott, Slatick, & Urman, 2001) 
 
 

































Appendix P. Change Interview Protocol  





































Appendix Q. Treatment Integrity Checklist  





















































Appendix Q. Treatment Integrity Checklist  






















































Appendix Q. Treatment Integrity Checklist 






















































Appendix Q. Treatment Integrity Checklist  























































Appendix Q. Treatment Integrity Checklist  
(continued; Hepner et al., 2011) 
 
 






































































Appendix T. Facilitator Focus Group Schedule 
Introduction  
- Welcome 
- I am holding this focus group to get an idea of the feasibility and initial of 
the OWG and research.  
- I will be recording today, I will be transcribing the data and analysing it. I 
will be transcribing the data and analysing it. I may use quotes in the report, 
but these will be anonymised and personally identifiable information will 
not be included in any reports written. 
 
I am going to ask you some structured questions about the intervention and the research 
element of the project to start with, and then finish with a more general discussion at 
the end.  
 
1. What was your experience of facilitating/observing the OWG? 
- How did you find the content of the OWG was to deliver? 
- How easy/difficult was it to stick to the content of the OWG? 
- How did the content of the OWG seem to fit with the groups’ difficulties? 
- Was there anything that helped you to facilitate the OWG? 
- In what ways did the OWG seem to help/or not help the participants? 
- Did you receive any feedback (positive/negative) about the OWG that was 
particularly memorable? Can you give some specific examples? 
- What do you think could have made the group more feasible to facilitate?  
 
2. What was your experience of the supporting the research element of the group? 
- How easy/difficult was it to support the research part of the OWG? 
- Was there anything that helped you to facilitate the research part of the 
OWG? 
- Did you receive any feedback (positive/negative) about the research part of 
OWG that was particularly memorable? Can you give some specific 
examples? 
-  What do you think could have improved the feasibility of the research    
element of the OWG? 
 
3. Thank you for all your answers, is there anything else you would like to add to 
any of your previous answers? Or any other thoughts you have had whilst we 














Appendix U. Example Treatment Manual 
 
 

































Appendix V. Interrater Reliability Data for Change Interview Data 
 
Rater Crosstabulation 
Count   
    Code    
identified 
Rater 2 
Total 3.00 4.00 5.00 5.50 
Rater 1 3.00 6 0 0 0 6 
4.00 0 4 0 0 4 
5.00 0 0 3 1 4 
5.50 0 0 2 0 2 










 Approx. Sig. 
Measure of Agreement Kappa .736 .128 4.797 .000 
N of Valid Cases 16    
a. Not assuming the null hypothesis. 






















Appendix W. Interrater Reliability Data for Convergence Codes 
 
Rater Crosstabulation 
Count   
 
Rater 2 
Total 1.00 2.00 3.00 4.00 
Rater1  1.00 3 0 0 0 3 
2.00 0 1 1 0 2 
3.00 0 0 2 0 2 
4.00 0 0 0 4 4 










 Approx. Sig. 
Measure of Agreement Kappa .875 .115 4.929 .000 
N of Valid Cases 11    
a. Not assuming the null hypothesis. 
b. Using the asymptotic standard error assuming the null hypothesis. 
 
 
